Digital Guide: Next-Generation Sequencing for Prostate Cancer
Dr. Michael Carducci of Johns Hopkins breaks down how next-generation sequencing can be used to help doctors find the best prostate cancer treatment.
Next-generation sequencing (NGS), a type of molecular testing, can help you and your doctor decide on the best course for prostate cancer treatment. This sort of testing may be recommended for men with advanced prostate cancer. Genetic or germline testing is also considered very important in both early and advanced stages of prostate cancer.
Here, Dr. Michael Carducci, a medical oncologist at Johns Hopkins Kimmel Cancer Center, explains how these tests help doctors determine the best course of care for men with prostate cancer.
Your Digital Guide begins below: 3 Chapters / 3 Video Segments
Spencer Poiset
Genetic mutations, either inherited (germline) or specific to the cancer (somatic), are becoming increasingly important in the personalized treatment of metastatic prostate cancer. Knowing what to do with the results of genetic testing is important in order to make informed decisions together with your healthcare team regarding the future treatment of your prostate cancer.
